The epidemiology, healthcare and societal burden and costs of asthma in the UK and its member nations: analyses of standalone and linked national databases.

BMC Med 2016 08 29;14(1):113. Epub 2016 Aug 29.

Asthma UK Centre for Applied Research, Centre for Medical Informatics, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, EH8 9AG, UK.

Background: There are a lack of reliable data on the epidemiology and associated burden and costs of asthma. We sought to provide the first UK-wide estimates of the epidemiology, healthcare utilisation and costs of asthma.

Methods: We obtained and analysed asthma-relevant data from 27 datasets: these comprised national health surveys for 2010-11, and routine administrative, health and social care datasets for 2011-12; 2011-12 costs were estimated in pounds sterling using economic modelling.

Results: The prevalence of asthma depended on the definition and data source used. The UK lifetime prevalence of patient-reported symptoms suggestive of asthma was 29.5 % (95 % CI, 27.7-31.3; n = 18.5 million (m) people) and 15.6 % (14.3-16.9, n = 9.8 m) for patient-reported clinician-diagnosed asthma. The annual prevalence of patient-reported clinician-diagnosed-and-treated asthma was 9.6 % (8.9-10.3, n = 6.0 m) and of clinician-reported, diagnosed-and-treated asthma 5.7 % (5.7-5.7; n = 3.6 m). Asthma resulted in at least 6.3 m primary care consultations, 93,000 hospital in-patient episodes, 1800 intensive-care unit episodes and 36,800 disability living allowance claims. The costs of asthma were estimated at least £1.1 billion: 74 % of these costs were for provision of primary care services (60 % prescribing, 14 % consultations), 13 % for disability claims, and 12 % for hospital care. There were 1160 asthma deaths.

Conclusions: Asthma is very common and is responsible for considerable morbidity, healthcare utilisation and financial costs to the UK public sector. Greater policy focus on primary care provision is needed to reduce the risk of asthma exacerbations, hospitalisations and deaths, and reduce costs.

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12916-016-0657-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5002970PMC
August 2016
45 Reads
22 Citations
7.250 Impact Factor

Publication Analysis

Top Keywords

primary care
12
costs asthma
12
asthma
12
prevalence patient-reported
8
healthcare utilisation
8
epidemiology healthcare
8
burden costs
8
costs
8
care
5
consultations 93000
4
63 m primary
4
care consultations
4
asthma 63 m
4
57-57 n = 36 m
4
asthma 57 %
4
57 % 57-57
4
93000 hospital
4
n = 36 m asthma
4
1800 intensive-care
4
episodes 36800
4

References

(Supplied by CrossRef)

J Mallol et al.
Allergologia et Immunopathologia 2013

R Gupta et al.
Clin Exp Allergy 2004

C Anandan et al.
JRSM 2009

C Anandan et al.
Allergy 2010

K Bahadori et al.
BMC Pulm Med. 2009

ML Levy et al.
Breathe 2015

M Mukherjee et al.
BMJ Open 2014

Similar Publications